Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Yes, but it varies between individuals
This personalized approach reduces trial-and-error adjustments and accelerates your path to an optimal, well-tolerated dose
Increase by one teaspoon every 3-4 days as tolerated
Important safety information: Tirzepatide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
In a new study by the University of Eastern Finland and Karolinska Institutet in Sweden, researchers found that people with alcohol use disorder (AUD) were less likely to be hospitalized for alcohol or substance abuse-related conditions
